한글목차

세계의 조직공학 시장은 2025년에 130억 2,000만 달러로 추정되며, 2032년에는 289억 7,000만 달러에 달할 것으로 예측되며, 2025-2032년 CAGR은 12.1%로 성장할 전망입니다.

도표. 조직공학 시장 지역별 점유율(%)(2025년)

조직공학은 조직 기능을 회복, 유지, 개선하기 위한 생물학적 대체물을 개발하기 위해 공학과 생명과학의 원리를 적용하는 다학제적 분야입니다. 새로운 조직의 성장을 지원하는 골격이라고 불리는 생물학적으로 불활성인 물질에 인간 세포를 파종하여 새로운 조직의 성장을 지원하는 것을 포함합니다. 조직공학 시장에는 손상된 조직이나 장기를 복구하거나 대체하는 데 사용되는 다양한 제품의 연구개발 및 제조가 포함됩니다. 만성질환의 유병률 증가, 근골격계 질환을 앓고 있는 노인 증가, 기술 발전이 이 시장 수요를 촉진하는 주요 요인으로 작용하고 있습니다. 그러나 조직공학 제품과 관련된 높은 비용과 바이오소재 및 줄기세포 사용과 관련된 윤리적 문제가 시장 확대를 제한하고 있습니다.

시장 역학

세계 조직공학 시장은 암, 심혈관 질환 등 만성질환의 유병률 증가로 인해 조직대체요법에 대한 높은 수요가 발생하고 있습니다. 정형외과적 질환에 취약한 노년층이 전 세계에서 급증하는 것도 주요 시장 성장 촉진요인 중 하나입니다. 세계보건기구(WHO)에 따르면 세계 60세 이상 인구의 비율은 2015-2050년 사이에 12%에서 22%로 거의 두 배로 증가할 것으로 예상됩니다. 또한 재생의료 부문의 지속적인 기술 발전으로 줄기세포, 생분해성 골격, 유전자 치료 기술을 통한 새로운 조직공학 제품 개발이 가능해졌습니다. 이에 따라 조직공학 치료의 적용 범위가 넓어지고 있습니다. 그러나 조직공학 시술 및 바이오소재 가공에 소요되는 높은 비용과 줄기세포 연구에 대한 규제 문제가 이 시장의 큰 장벽으로 작용하고 있습니다. 또한 복잡한 조직공학 수술을 수행할 수 있는 숙련된 전문가의 부족도 시장 성장에 걸림돌로 작용하고 있습니다. 골격이 되는 생체 재료의 제조 비용을 낮추는 데 초점을 맞춘 연구개발이 진행 중이며, 맞춤형 의료 접근법의 채택은 이해관계자들에게 유리한 기회를 제공합니다.

본 조사의 주요 특징

• 이 보고서는 세계 조직공학 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR%)을 게재하고 있습니다.
• 또한 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 세계 조직공학 시장의 주요 기업을 기업 소개, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개변수를 기반으로 프로파일링합니다.
• 주요 기업에는 Acelity L.P. Inc., AbbVie Inc., B. Braun SE, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Tissue Regenix Group Plc., Zimmer Biomet 등이 있습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 조직 공학 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 세계 조직공학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자들은 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 제조업체 매출
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 조직공학 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 조직공학 시장, 이식 유형별, 2020-2032년(10억 달러)

• 서론
• 동종 이식
• 자가 이식
• 이종 이식

제6장 세계의 조직공학 시장, 재료 유형별, 2020-2032년(10억 달러)

• 서론
• 합성
• 생물학적
• 기타

제7장 세계의 조직공학 시장, 용도별, 2020-2032년(10억 달러)

• 서론
• 피부
• 정형외과
• 치과
• 신경학
• 기타

제8장 세계의 조직공학 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Acelity LP Inc.
  • AbbVie Inc.
  • B. Braun SE
  • BioMimetic Therapeutics
  • Bio Tissue Technologies
  • CR Bard
  • International Stem Cell
  • Integra Lifesciences
  • Organogenesis Inc.
  • Osiris Therapeutics
  • RTI surgical, Inc.
  • Tissue Regenix Group Plc.
  • Zimmer Biomet

제10장 애널리스트의 시점

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Tissue Engineering Market is estimated to be valued at USD 13.02 Bn in 2025 and is expected to reach USD 28.97 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2032.

Figure. Tissue Engineering Market Share (%), By Region 2025

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences towards developing biological substitutes to restore, maintain, or improve tissue function. It involves seeding human cells onto biologically inert materials called scaffolds that can support new tissue growth. The tissue engineering market involves the research, development, and manufacturing of various products used for repairing or replacing damaged tissues and organs. Rising prevalence of chronic diseases, growth in geriatric population suffering from musculoskeletal disorders, and technological advancements are the major factors fueling demand in this market. However, high costs associated with tissue engineering products and ethical issues related to the use of biomaterials and stem cells limits market expansion.

Market Dynamics:

The global tissue engineering market is driven by the increasing incidence of chronic diseases such as cancer and cardiovascular diseases that generate high demand for tissue replacement therapies. Rapid growth in geriatric population worldwide who are highly prone to orthopedic conditions is another key market driver. According to World Health Organization, the proportion of world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Furthermore, continuous technological advancements in the field of regenerative medicine has enabled development of novel tissue engineered products based on stem cells, biodegradable scaffolds, and gene therapy techniques. This has expanded applications of tissue engineering therapy. However, high costs of tissue engineering procedures, biomaterial processing and regulatory issues pertaining to stem cell research act as major barriers to the market. Lack of skilled professionals to perform complex tissue engineering surgeries also challenges market growth. Nonetheless, ongoing R&D focused on lowering manufacturing costs of scaffold biomaterials and adoption of personalized medicine approach presents lucrative opportunities for stakeholders.

Key Features of the Study:

• This report provides an in-depth analysis of the global tissue engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global tissue engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Acelity L.P. Inc., AbbVie Inc., B. Braun SE, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Tissue Regenix Group Plc., and Zimmer Biomet.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global tissue engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue engineering market.

Detailed Segmentation-

• By Graft Type:
  • Allografts
  • Autografts
  • Xenografts
• By Material Type:
  • Synthetic
  • Biological
  • Others
• By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Acelity L.P. Inc.
  • AbbVie Inc.
  • Braun SE
  • BioMimetic Therapeutics
  • Bio Tissue Technologies
  • C.R. Bard
  • International Stem Cell
  • Integra Lifesciences
  • Organogenesis Inc.
  • Osiris Therapeutics
  • RTI surgical, Inc.
  • Tissue Regenix Group Plc.
  • Zimmer Biomet

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Graft Type
  • Market Snapshot, By Material Type
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Tissue Engineering Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Tissue Engineering Market, By Graft Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Allografts
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autografts
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Xenografts
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Tissue Engineering Market, By Material Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Synthetic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biological
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Tissue Engineering Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Dermal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Orthopedic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dental
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Tissue Engineering Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Acelity L.P. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BioMimetic Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio Tissue Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • C. R. Bard
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • International Stem Cell
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integra Lifesciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Organogenesis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Osiris Therapeutics
  • RTI surgical, Inc.
  • Tissue Regenix Group Plc.
  • Zimmer Biomet

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact